{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T11:47:28Z","timestamp":1765540048669,"version":"3.48.0"},"reference-count":32,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T00:00:00Z","timestamp":1669334400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,3,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_jcim-2022-0034_abs_001\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>The support provided by conventional treatments centered on the administration of medication for chronic or other types of depression is limited. Integrative medicine, which is based on both modern Western medicine and a range of complementary and alternative medicine practices, is patient-centered and promotes natural healing in patients to achieve significant cure. This\u00a0report focuses on the indications of recovery from\u00a0depression using integrative medicine, especially homeopathy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jcim-2022-0034_abs_002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Thirty-one patients (9 males and 22 females) with depression underwent homeopathic treatment using various strategies over 3\u00a0months, in addition to antidepressants. All patients were diagnosed with Major Depressive Disorders, except bipolar disorders. Three steps were used to model indications of their recovery from depression: reducing difficulties in everyday life, reducing and stopping antidepressants, and reducing and stopping the homeopathic remedies. Patients were considered to have recovered when antidepressants had been stopped for 6\u00a0months or more and 3 or more months had passed since homeopathic medicines were stopped.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jcim-2022-0034_abs_003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 31 patients with depression, 13 recovered within 2\u00a0years of starting homeopathic treatment, and 11 completely recovered from chronic depression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jcim-2022-0034_abs_004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study suggests that integrative medicine can be a useful strategy for depression, including the use of a three-step strategy for reducing all dependence on clinical treatment. As most patients, especially chronic patients, significantly recovered from depression through homeopathy over 2\u00a0years, this model can help understand recovery from depression through integrative medicine.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/jcim-2022-0034","type":"journal-article","created":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T01:50:20Z","timestamp":1669341020000},"page":"120-128","source":"Crossref","is-referenced-by-count":0,"title":["Integrative medicine approaches to chronic depression: case studies of the recovery process with a three-step path to recovery and significant cure"],"prefix":"10.1515","volume":"20","author":[{"given":"Ronko","family":"Itamura","sequence":"first","affiliation":[{"name":"Clinical Director, Physics Clinic for Integrative Medicine , Tokyo , Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2022,11,25]]},"reference":[{"key":"2025121209102107268_j_jcim-2022-0034_ref_001","unstructured":"World Health Organization. \u201cDepression: let\u2019s talk\u201d say WHO, as depression tops list of causes of ill health [Online]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/depression [Accessed 15 Nov 2020]."},{"key":"2025121209102107268_j_jcim-2022-0034_ref_002","unstructured":"Ministry of Health, Labour and Welfare. Available from: https:\/\/www.mhlw.go.jp\/wp\/hakusyo\/jisatsu\/19\/dl\/1-1.pdf [Accessed 15 Nov 2020]."},{"key":"2025121209102107268_j_jcim-2022-0034_ref_003","doi-asserted-by":"crossref","unstructured":"Carvalho, AF, Cavalcante, JL, Castelo, MS, Lima, MC. Augmentation strategies for treatment-resistant depression: a literature review. J Clin Pharm Therapeut 2007;32:415\u201328. https:\/\/doi.org\/10.1111\/j.1365-2710.2007.00846.x.","DOI":"10.1111\/j.1365-2710.2007.00846.x"},{"key":"2025121209102107268_j_jcim-2022-0034_ref_004","doi-asserted-by":"crossref","unstructured":"Thase, ME, Haight, BR, Richard, N, Rockett, CB, Mitton, M, Modell, JG. Remission rates following antidepressant therapy with bupropion or selective serotonin reuptake inhibitors: a meta-analysis of original data from 7 randomized controlled trials. J Clin Psychiatr 2005;66:974\u201381. https:\/\/doi.org\/10.4088\/jcp.v66n0803.","DOI":"10.4088\/JCP.v66n0803"},{"key":"2025121209102107268_j_jcim-2022-0034_ref_005","doi-asserted-by":"crossref","unstructured":"Machado, M, Iskedjian, M, Ruiz, I, Einarson, TR. Remission, dropouts, and adverse drug reaction rates in major depressive disorder: a meta-analysis of head-to-head trials. Curr Med Res Opin 2006;22:1825\u201337. https:\/\/doi.org\/10.1185\/030079906X132415.","DOI":"10.1185\/030079906X132415"},{"key":"2025121209102107268_j_jcim-2022-0034_ref_006","doi-asserted-by":"crossref","unstructured":"Wang, PS, Aguilar-Gaxiola, S, Alonso, J, Angermeyer, MC, Borges, G, Bromet, EJ. Use of mental health services for anxiety, mood, and substance disorders in 17 countries in the WHO world mental health surveys. Lancet 2007;370:841\u201350. https:\/\/doi.org\/10.1016\/S0140-6736(07)61414-7.","DOI":"10.1016\/S0140-6736(07)61414-7"},{"key":"2025121209102107268_j_jcim-2022-0034_ref_007","doi-asserted-by":"crossref","unstructured":"Un\u00fctzer, J, Klap, R, Sturm, R. Mental disorders and the use of alternative medicine: results from a national survey. Am J Psychiatr 2000;157:1851\u20137. https:\/\/doi.org\/10.1176\/appi.ajp.157.11.1851.","DOI":"10.1176\/appi.ajp.157.11.1851"},{"key":"2025121209102107268_j_jcim-2022-0034_ref_008","doi-asserted-by":"crossref","unstructured":"Solomon, D, Adams, J. The use of complementary and alternative medicine in adults with depressive disorders. A critical integrative review. J Affect Disord 2015;179:101\u201313. https:\/\/doi.org\/10.1016\/j.jad.2015.03.031.","DOI":"10.1016\/j.jad.2015.03.031"},{"key":"2025121209102107268_j_jcim-2022-0034_ref_009","doi-asserted-by":"crossref","unstructured":"Pratap, RC. Can an integrative approach to the management of depression help patients achieve functional recovery? A review of current literature. J Depress Anxiety 2013;2. https:\/\/doi.org\/10.4172\/2167-1044.1000141.","DOI":"10.4172\/2167-1044.1000141"},{"key":"2025121209102107268_j_jcim-2022-0034_ref_010","unstructured":"Leckridge, B. Homeopathy in primary care. New York: Churchill Livingstone; 1997."},{"key":"2025121209102107268_j_jcim-2022-0034_ref_011","unstructured":"Kaye, BS. Homeopathic practice. London: Pharmaceutical Press; 2007."},{"key":"2025121209102107268_j_jcim-2022-0034_ref_012","doi-asserted-by":"crossref","unstructured":"First, MB, Pincus, HA. The DSM-IV text revision: rationale and potential impact on clinical practice. Psychiatr Serv 2002;53:288\u201392. https:\/\/doi.org\/10.1176\/appi.ps.53.3.288.","DOI":"10.1176\/appi.ps.53.3.288"},{"key":"2025121209102107268_j_jcim-2022-0034_ref_013","doi-asserted-by":"crossref","unstructured":"Zung, WWK. A self-rating depression scale. Arch Gen Psychiatr 1965;12:63\u201370. https:\/\/doi.org\/10.1001\/archpsyc.1965.01720310065008.","DOI":"10.1001\/archpsyc.1965.01720310065008"},{"key":"2025121209102107268_j_jcim-2022-0034_ref_014","doi-asserted-by":"crossref","unstructured":"Broadman, K, Erdmann, AJ, Lorge, I, Wolf, HG. The Cornell Medical Index-health questionnaire. II. As a diagnostic instrument. J Am Med Assoc 1951;145:152\u20137. https:\/\/doi.org\/10.1001\/jama.1951.02920210024006.","DOI":"10.1001\/jama.1951.02920210024006"},{"key":"2025121209102107268_j_jcim-2022-0034_ref_015","doi-asserted-by":"crossref","unstructured":"Hirschfeld, RM, Montgomery, SA, Aguglia, E, Amore, M, Delgado, PL, Gastpar, M, et al.. Partial response and nonresponse to antidepressant therapy: current approaches and treatment options. J Clin Psychiatr 2002;63:826\u201337. https:\/\/doi.org\/10.4088\/jcp.v63n0913.","DOI":"10.4088\/JCP.v63n0913"},{"key":"2025121209102107268_j_jcim-2022-0034_ref_016","doi-asserted-by":"crossref","unstructured":"Geddes, JR, Carney, SM, Davies, C, Furukawa, TA, Kupfer, DJ, Frank, E, et al.. Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet 2003;361:653\u201361. https:\/\/doi.org\/10.1016\/S0140-6736(03)12599-8.","DOI":"10.1016\/S0140-6736(03)12599-8"},{"key":"2025121209102107268_j_jcim-2022-0034_ref_017","doi-asserted-by":"crossref","unstructured":"Prien, RF, Kupfer, DJ. Continuation drug therapy for major depressive episodes: how long should it be maintained? Am J Psychiatr 1986;143:18\u201323. https:\/\/doi.org\/10.1176\/ajp.143.1.18.","DOI":"10.1176\/ajp.143.1.18"},{"key":"2025121209102107268_j_jcim-2022-0034_ref_018","unstructured":"American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder (revision). Am J Psychiatr 2000;157:1\u201345."},{"key":"2025121209102107268_j_jcim-2022-0034_ref_019","doi-asserted-by":"crossref","unstructured":"Fibiger, HC. Psychiatry, the pharmaceutical industry, and the road to better therapeutics. Schizophr Bull 2012;38:649\u201350. https:\/\/doi.org\/10.1093\/schbul\/sbs073.","DOI":"10.1093\/schbul\/sbs073"},{"key":"2025121209102107268_j_jcim-2022-0034_ref_020","doi-asserted-by":"crossref","unstructured":"M\u00f6ller, HJ. Outcomes in major depressive disorder: the evolving concept of remission and its implications for treatment. World J Biol Psychiatr 2008;9:102\u201314. https:\/\/doi.org\/10.1080\/15622970801981606.","DOI":"10.1080\/15622970801981606"},{"key":"2025121209102107268_j_jcim-2022-0034_ref_021","doi-asserted-by":"crossref","unstructured":"Rief, W, Nestoriuc, Y, Weiss, S, Welzel, E, Barsky, A, Hofmann, S. Meta-Analysis of the placebo response in antidepressant trials. J Affect Disord 2009;118:1\u20138. https:\/\/doi.org\/10.1016\/j.jad.2009.01.029.","DOI":"10.1016\/j.jad.2009.01.029"},{"key":"2025121209102107268_j_jcim-2022-0034_ref_022","doi-asserted-by":"crossref","unstructured":"Forneris, CA, Nussbaumer, B, Kaminski-Hartenthaler, A, Morgan, LC, Gaynes, BN, Sonis, JH, et al.. Psychological therapies for preventing seasonal affective disorder. Cochrane Database Syst Rev 2015;46:CD011270.","DOI":"10.1002\/14651858.CD011270.pub2"},{"key":"2025121209102107268_j_jcim-2022-0034_ref_023","doi-asserted-by":"crossref","unstructured":"Gartlehner, G, Nussbaumer, B, Gaynes, BN, Forneris, CA, Morgan, LC, Greenblatt, A, et al.. Second-Generation antidepressants for preventing seasonal affective disorder in adults. Cochrane Database Syst Rev 2015;58:CD011268.","DOI":"10.1002\/14651858.CD011268.pub2"},{"key":"2025121209102107268_j_jcim-2022-0034_ref_024","unstructured":"Benjamin, JS, Virginia, AS. Kaplan & Sadock\u2019s synopsis of psychiatry. Behavioral science\/clinical psychiatry, 10th ed. New York: Wolters Kluwer; 2007. p.\u00a0839."},{"key":"2025121209102107268_j_jcim-2022-0034_ref_025","unstructured":"Hahnemann, S. Organon of the medicl art, 6th ed. Redmond, Washington: O\u2019reilly W.B.; 1996:65 p."},{"key":"2025121209102107268_j_jcim-2022-0034_ref_026","doi-asserted-by":"crossref","unstructured":"Itamura, R, Hosoya, R. Homeopathic treatment of patients with intractable atopic dermatitis. Homeopathy 2003;92:108\u201314. https:\/\/doi.org\/10.1016\/s1475-4916(03)00017-1.","DOI":"10.1016\/S1475-4916(03)00017-1"},{"key":"2025121209102107268_j_jcim-2022-0034_ref_027","doi-asserted-by":"crossref","unstructured":"Itamura, R. Effect of homeopathic treatment of sixty Japanese patients with chronic skin disease. Compl Ther Med 2007;15:115\u201320. https:\/\/doi.org\/10.1016\/j.ctim.2006.04.005.","DOI":"10.1016\/j.ctim.2006.04.005"},{"key":"2025121209102107268_j_jcim-2022-0034_ref_028","doi-asserted-by":"crossref","unstructured":"Davidson, JR, Crawford, C, Ives, JA, Jonas, WB. Homeopathic treatments in psychiatry: a systematic review of randomized placebo-controlled studies. J Clin Psychiatr 2011;72:795\u2013805. https:\/\/doi.org\/10.4088\/jcp.10r06580.","DOI":"10.4088\/JCP.10r06580"},{"key":"2025121209102107268_j_jcim-2022-0034_ref_029","doi-asserted-by":"crossref","unstructured":"Rotella, F, Cassioli, E, Falone, A, Ricca, V, Mannucci, E. Homeopathic remedies in psychiatric disorders: a meta-analysis of randomized controlled trials. J Clin Psychopharmacol 2020;40:269\u201375. https:\/\/doi.org\/10.1097\/jcp.0000000000001196.","DOI":"10.1097\/JCP.0000000000001196"},{"key":"2025121209102107268_j_jcim-2022-0034_ref_030","doi-asserted-by":"crossref","unstructured":"Katz, T, Fisher, P, Katz, A, Davidson, J, Feder, G. The feasibility of randomized, placebo-controlled clinical trial of homeopathic treatment of depression in general practice. Homeopathy 2005;94:145\u201352. https:\/\/doi.org\/10.1016\/j.homp.2005.04.002.","DOI":"10.1016\/j.homp.2005.04.002"},{"key":"2025121209102107268_j_jcim-2022-0034_ref_031","doi-asserted-by":"crossref","unstructured":"Adler, UC, Paiva, NMP, Cesar, AT, Adler, MS, Molina, A, Padula, AE, et al.. Homeopathic individualized Q-potencies versus fluoxetine for moderate to severe depression: double-blind, randomized non-inferiority trial. Evid Complement Alternat Med 2011;2011:520182. https:\/\/doi.org\/10.1093\/ecam\/nep114.","DOI":"10.1093\/ecam\/nep114"},{"key":"2025121209102107268_j_jcim-2022-0034_ref_032","doi-asserted-by":"crossref","unstructured":"del Carmen Macias-Cortes, E, Llanes-Gonzales, L, Aguilar-Faisal, L, Asbun-Bojalil, J. Individualized Homeopathic treatment and fluoxetine for moderate to severe depression in peri-and postmenopausal women (HOMDEP-MENOP Study): a randomized, double-dummy, double-blind, placebo-controlled trial. PLoS One 2015;10:e0118440. https:\/\/doi.org\/10.1371\/journal.pone.0118440.","DOI":"10.1371\/journal.pone.0118440"}],"container-title":["Journal of Complementary and Integrative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jcim-2022-0034\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jcim-2022-0034\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T11:43:24Z","timestamp":1765539804000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jcim-2022-0034\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,25]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,11,16]]},"published-print":{"date-parts":[[2023,3,14]]}},"alternative-id":["10.1515\/jcim-2022-0034"],"URL":"https:\/\/doi.org\/10.1515\/jcim-2022-0034","relation":{},"ISSN":["1553-3840"],"issn-type":[{"type":"electronic","value":"1553-3840"}],"subject":[],"published":{"date-parts":[[2022,11,25]]}}}